HIVMA submitted comments urging HUD to withdraw its proposed rule that would allow housing providers to deny services to transgender individuals.

In a letter to U.S. Food and Drug Administration leaders today, more than 90 organizations representing physicians and other health providers, as well as scientists, patients and medical advocates, urge the agency to ensure that reviews of COVID-19 vaccine candidates meet all regulatory standards prior to authorization or licensure.

With funding from the Centers for Disease Control and Prevention, the Infectious Diseases Society of America has launched the COVID-19 Real-Time Learning Network microsite. The site brings together the latest clinical guidance, institutional protocols, clinical trials data, practice tools and resources from a variety of medical subspecialties around the world.

As the United Nations General Assembly opens for the first time in its 75-year history without an on-site gathering of world leaders, the critical need for international collaboration to end the current pandemic and prevent the next one should be clearer and more compelling than ever.

In a new policy paper, IDSA and HIVMA call for urgent action to reduce illness and death associated with the overlapping epidemics of injection drug use and infectious diseases, outlining key steps needed now more than ever during the COVID-19 pandemic.